Bio-Techne (TECH) Depreciation & Amortization (CF) (2009 - 2026)

Bio-Techne's Depreciation & Amortization (CF) history runs 18 years deep, the most recent figure standing at $24.2 million for Q1 2026.

• On a quarterly basis, Depreciation & Amortization (CF) fell 12.34% year-over-year to $24.2 million in Q1 2026; TTM through Mar 2026 was $100.3 million, a 9.49% decrease from a year earlier, with the FY2025 full-year figure at $109.9 million, down 1.62% from the prior year.
• Depreciation & Amortization (CF) eased to $24.2 million in Q1 2026 per TECH's latest filing, from $24.7 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $28.5 million in Q3 2023 and bottomed at $24.2 million in Q1 2026.
• The 5-year median for Depreciation & Amortization (CF) is $27.0 million (2023), against an average of $26.7 million.
• Across the five-year window, Depreciation & Amortization (CF) rose 20.21% in 2022 and declined 13.49% in 2025, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $26.7 million in 2022, then increased by 4.12% to $27.8 million in 2023, then declined by 2.59% to $27.1 million in 2024, then decreased by 8.77% to $24.7 million in 2025, then decreased by 2.19% to $24.2 million in 2026.
• Per Business Quant, the three latest TECH Depreciation & Amortization (CF) figures stand at $24.2 million (Q1 2026), $24.7 million (Q4 2025), and $24.3 million (Q3 2025).